| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.5M | +1.6% |
| Cost of Revenue | $40.5M | -0.3% |
| Gross Profit | $30.0M | +4.4% |
| R&D Expense | $9.7M | +15.5% |
| SG&A Expense | $17.7M | +16.3% |
| Operating Income | -$24.7M | -11.1% |
| Pre-tax Income | -$28.8M | -42.1% |
| Income Tax | $438K | +39.9% |
| Net Income | -$29.2M | -42.1% |
| EPS (Basic) | -$0.78 | -41.8% |
| EPS (Diluted) | -$0.78 | -41.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $20.5M | -34.0% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $21.3M | +10.2% |
| Inventory | $12.8M | -33.2% |
| Current Assets | $57.2M | -21.3% |
| Total Assets | $79.0M | -11.6% |
| Current Liabilities | $37.1M | -5.4% |
| Long-term Debt |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.4M | -11.6% |
| Investing Cash Flow | -$5.7M | -28.2% |
| Financing Cash Flow | $8.6M | +71.7% |
| $18.0M |
| +279.5% |
| Total Liabilities | $59.6M | +27.0% |
| Stockholders' Equity | $19.4M | -54.3% |